Increased urinary transforming growth factor- beta1 excretion in children with posterior urethral valves

Urology

Volumn 56, Issue 2, 2000, Pages 311-314

  MacRae Dell, Katherine ^c   Hoffman, Brenda B ^b   Leonard, Mary B ^a,b   Ziyadeh, Fuad N ^b   Schulman, Seth L ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ARTICLE; BLADDER MALFORMATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; KIDNEY FAILURE; MALE; MESANGIUM; NORMAL HUMAN; PRIORITY JOURNAL; URETHRA VALVE; URINALYSIS; URINARY DIVERSION; URINARY EXCRETION;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KIDNEY FAILURE; MALE; PILOT PROJECTS; SEX FACTORS; TRANSFORMING GROWTH FACTOR BETA; URETHRA; URETHRAL OBSTRUCTION;

EID: 0033944717     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00591-4     Document Type: Article

References (17)

1. Peters H., Noble N.A., Border W.A. Transforming growth factor-β in human glomerular injury. Curr Opin Nephrol Hypertens. 6:1997;389-393.
2. Chung K.H., Chevalier R.L. Arrested development of the neonatal kidney following chronic ureteral obstruction. J Urol. 155:1996;1139-1144.
3. 1 in obstructive nephropathy. Kidney Int. 48:1995;1233-1246.
4. 1 in patients with type II diabetes. Diabetes. 46:1997;854-859.
5. 1 in patients with glomerular diseases. Pediatr Nephrol. 11:1997;334-336.
6. Kanai H., Mitsuhashi H., Ono K., et al. Increased excretion of urinary transforming growth factor beta in patients with focal glomerular sclerosis. Nephron. 66:1994;391-395.
7. Schwartz G.J., Brion L.P., Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am. 34:1987;571-590.
8. Shihab F., Yamamoto T., Nast C., et al. Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts. J Am Soc Nephrol. 6:1995;286-294.
9. Klahr S., Morrissey J. The role of growth factors, cytokines and vasoactive compounds in obstructive nephropathy. Semin Nephrol. 18:1998;622-632.
10. 1 mRNA expression in the renal pelvis after experimental and clinical ureteropelvic junction obstruction. J Urol. 156:1996;261-266.
11. Azadzoi K., Tarcan T., Siroky M., et al. Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-conpliance in the rabbit. J Urol. 161:1999;1626-1635.
12. 1 in children with ureteropelvic junction obstruction. Urology. 50:1997;769-773.
13. Furness P., Maizels M., Han S., et al. Elevated bladder urine concentration of transforming growth factor-beta 1 correlates with upper urinary tract obstruction in children. J Urol. 162:1999;1033-1036.
14. Smith G.H.H., Canning D.A., Schulman S.L., et al. The long-term outcome of posterior urethral valves treated with primary valve ablation and observation. J Urol. 155:1996;1730-1734.
15. Wolf G., Mueller E., Stahl R.A.K., et al. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous TGF-β J Clin Invest. 92:1993;1366-1373.
16. Lewis E.J., Hunsicker L.G., Bain R.P., et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 329:1993;1456-1462.
17. Ishidoya S., Morrissey J., McCracken R., et al. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int. 49:1996;1110-1119.